Dennis Mulroy
Chief Financial Officer · Arcturus Therapeutics Holdings Inc.
- 2026
- May 7, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dennis Mulroy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Faga - $2.14M in ANAB purchases and sales in the last 12 months
- John P. Schmid - $1.16M in ANAB purchases and sales in the last 12 months
- Eric J. Loumeau - $1.08M in ANAB purchases and sales in the last 12 months
- Magda Marquet - $531K in ANAB purchases and sales in the last 12 months
- Paul F. Lizzul - $264K in ANAB purchases and sales in the last 12 months
- Hollings Renton - $249K in ANAB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dennis Mulroy?
Dennis Mulroy is a corporate insider, tracked as Chief Financial Officer of Arcturus Therapeutics Holdings Inc. (ARCT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Dennis Mulroy last file a Form 4?
The most recent primary Form 4 on record is dated 7 May 2026, one of 3 filings going back to 2026.
Has Dennis Mulroy been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($199K) across all tracked filings.
